US2020297660A1PendingUtilityA1
Applications of spermine and derivatives thereof
Assignee: GENEHEAL BIOTECHNOLOGY CO LTDPriority: Sep 29, 2016Filed: Jun 1, 2020Published: Sep 24, 2020
Est. expirySep 29, 2036(~10.2 yrs left)· nominal 20-yr term from priority
C07C 221/00A61K 31/198C07D 501/57A61P 3/00A61K 38/06A61P 25/14C07F 9/90A61P 25/08A61K 31/341C07D 405/14A61P 43/00C07C 249/00A61K 31/663A61K 31/132C07C 209/00A61K 8/41A61K 31/16A61K 31/00A61K 38/17A61K 31/427A61K 31/407
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure relates to a method for treating a disease which can be alleviated by inhibiting PAICS activity. The method includes administering a therapeutically effective amount of spermine or a pharmaceutically acceptable salt or C1-C6 amide thereof to a patient in need thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating a disease which can be alleviated by inhibiting PAICS activity, comprising:
administering a therapeutically effective amount of spermine or a pharmaceutically acceptable salt or C 1 -C 6 amide thereof to a patient in need thereof
2 . The method of claim 1 , wherein the method comprises administering spermine to the patient.
3 . The method of claim 1 , wherein the method comprises administering a pharmaceutically acceptable salt of spermine to the patient.
4 . The method of claim 3 , wherein the pharmaceutically acceptable salt is prepared from spermine and an acid selected from the group consisting of acetic acid, 2,2-dichloroacetic acid, adipic acid, alginic acid, ascorbic acid, L-aspartic acid, benzenesulfonic acid, benzoic acid, 4-acetylamino benzoic acid, butyric acid, (+)-camphoric acid, camphor sulfonic acid, (+)-(1S)-camphor-10-sulfonic acid, capric acid, hexanoic acid, octanoic acid, cinnamic acid, citric acid, cyclamic acid, dodecylsulfuric acid, ethane-1,2-disulfonic acid, ethanesulfonic acid, 2-hydroxyethanesulfonic acid, formic acid, fumaric acid, galactonic acid, gentisic acid, glucoheptonic acid, D-gluconic acid, glucuronic acid, glutamic acid, a-ketoglutaric acid, glycolic acid, hippuric acid, hydrobromic acid, hydrochloric acid, hydroiodic acid, hydroxyethylsulfonic acid, (+)-L-lactic acid, (+)-DL-lactic acid, lactobionic acid, maleic acid, malic acid, (−)-L-malic acid, malonic acid, (±)-DL-mandelic acid, methanesulfonic acid, naphthalene-2-sulfonic acid, naphthalene-1,5-disulfonic acid, 1-hydroxyl-2-naphthoic acid, nicotinic acid, nitric acid, oleic acid, orotic acid, oxalic acid, palmitic acid, pamoic acid, phosphoric acid, propionic acid, L-pyroglutamic acid, salicylic acid, 4-aminosalicylic acid, sebacic acid, stearic acid, succinic acid, sulfuric acid, tannic acid, (+)-L-tartaric acid, sulfocyanic acid, p-toluenesulfonic acid, undecylenic acid, pentanoic acid, and acyl-amino acid.
5 . The method of claim 1 , wherein the disease comprises a tumor with high expression of PAICS.
6 . A method for treating or alleviating a disease caused by excessive accumulation of SAICAR, SAICAr or S-Ado, comprising:
administering a therapeutically effective amount of spermine or a pharmaceutically acceptable salt or C 1 -C 6 amide thereof to a patient in need thereof.
7 . The method of claim 6 , wherein the method comprises administering spermine to the patient.
8 . The method of claim 6 , wherein the method comprises administering a pharmaceutically acceptable salt of spermine to the patient.
9 . The method of claim 8 , wherein the pharmaceutically acceptable salt is prepared from spermine and an acid selected from the group consisting of acetic acid, 2,2-dichloroacetic acid, adipic acid, alginic acid, ascorbic acid, L-aspartic acid, benzenesulfonic acid, benzoic acid, 4-acetylamino benzoic acid, butyric acid, (+)-camphoric acid, camphor sulfonic acid, (+)-(1S)-camphor-10-sulfonic acid, capric acid, hexanoic acid, octanoic acid, cinnamic acid, citric acid, cyclamic acid, dodecylsulfuric acid, ethane-1,2-disulfonic acid, ethanesulfonic acid, 2-hydroxyethanesulfonic acid, formic acid, fumaric acid, galactonic acid, gentisic acid, glucoheptonic acid, D-gluconic acid, glucuronic acid, glutamic acid, a-ketoglutaric acid, glycolic acid, hippuric acid, hydrobromic acid, hydrochloric acid, hydroiodic acid, hydroxyethylsulfonic acid, (+)-L-lactic acid, (+)-DL-lactic acid, lactobionic acid, maleic acid, malic acid, (−)-L-malic acid, malonic acid, (±)-DL-mandelic acid, methanesulfonic acid, naphthalene-2-sulfonic acid, naphthalene-1,5-disulfonic acid, 1-hydroxyl-2-naphthoic acid, nicotinic acid, nitric acid, oleic acid, orotic acid, oxalic acid, palmitic acid, pamoic acid, phosphoric acid, propionic acid, L-pyroglutamic acid, salicylic acid, 4-aminosalicylic acid, sebacic acid, stearic acid, succinic acid, sulfuric acid, tannic acid, (+)-L-tartaric acid, sulfocyanic acid, p-toluenesulfonic acid, undecylenic acid, pentanoic acid, and acyl-amino acid.Join the waitlist — get patent alerts
Track US2020297660A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.